Showing results (91-100 of 155) with videos related to
Sort By:
Pageof 16
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 30, 2003
Use of restenting should be minimized with intracoronary radiation therapy for in-stent restenosisDong-Hun Cha, Ishtiaq A Malik, Edouard Cheneau, et al.The American Journal of Cardiology|October 23, 2008
Comparison of safety, efficacy, and outcome of successful versus unsuccessful percutaneous coronary intervention in "true" chronic total occlusionsAxel de Labriolle, Laurent Bonello, Probal Roy, et al.The American Journal of Cardiology|January 20, 2012
Comparison of outcome of higher versus lower transvalvular gradients in patients with severe aortic stenosis and low (<40%) left ventricular ejection fractionItsik Ben-Dor, Gabriel Maluenda, Getachew D Iyasu, et al.Archives of Cardiovascular Diseases|April 21, 2009
Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stentsAxel De Labriolle, Laurent Bonello, Gilles Lemesle, et al.The New England Journal of Medicine|April 19, 2002
Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass graftsRon Waksman, Andrew E Ajani, R Larry White, et al.The American Journal of Cardiology|September 1, 2014
Coronary blood flow in patients with severe aortic stenosis before and after transcatheter aortic valve implantationItsik Ben-Dor, Rahul Malik, Sa'ar Minha, et al.Journal of Interventional Cardiology|March 27, 2010
Clinical experience with a novel intracoronary perfusion catheter to treat no-reflow phenomenon in acute coronary syndromesGabriel Maluenda, Itsik Ben-Dor, Cedric Delhaye, et al.The American Journal of Cardiology|December 31, 2002
Comparison of intracoronary gamma radiation for in-stent restenosis in saphenous vein grafts versus native coronary arteriesAndrew E Ajani, Ron Waksman, Edouard Cheneau, et al.The American Journal of Cardiology|May 21, 2008
Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levelsProbal Roy, Vikram Raya, Teruo Okabe, et al.Journal of the American College of Cardiology|October 7, 2004
Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) studyRon Waksman, Andrew E Ajani, Augusto D Pichard, et al.Pageof 16